Trademark Overview
On Tuesday, November 4, 2025, a trademark application was filed for OMNIULTRA with the United States Patent and Trademark Office. The USPTO has given the OMNIULTRA trademark a serial number of 99477945. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, November 4, 2025. This trademark is owned by Crystal Bioscience, Inc.. The OMNIULTRA trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
synthesized peptides for scientific and research use; reagents for biological and chemical purposes and for research purposes, excluding those for medical or veterinary use; proteins and synthesized peptides used in the research and the development and manufacture of pharmaceuticals and biologicals; chemical reagents used for the detection, measurement and identification of genetic materials or compounds, excluding those for medical and veterinary use; biological tissue, namely, animal tissue for use in scientific and medical research; cells for scientific and research use; stem cells for scientific and research use; antibodies for use in further scientific and medical research
testing, examination, namely, inspection and research services in the field of the analysis and synthesis of peptides and antibodies, and the provision of information or advice thereto; testing, examination, namely, inspection and research services in the field of the analysis and synthesis of proteins, and the provision of information or advice thereto; quality control of peptides and antibodies used in drug development; advice on quality control of peptides and antibodies used in drug development; scientific research and development; scientific research and development in the field of immunization and antibody screening
manufacture of synthetic peptides and antibodies to the order and specification of others; peptide and antibody synthesis for others, namely, manufacture of synthetic peptides and antibodies to the order and specification of others
synthesized peptides for medical use; reagents for biological and chemical purposes and for medical use; chemical reagents used for the detection, measurement and identification of genetic materials or compounds for medical use; biological tissue, namely, animal tissue for medical purposes; cells for scientific and research use; antibodies for use medical use; radiopharmaceutical compositions for diagnostic or therapeutic use, namely, diagnostic radiopharmaceutical preparations and radiopharmaceuticals for the diagnosis or treatment of cancer, cardiovascular disease, lung disease, thyroid disease, bone disease, brain disease, and bodily tissue disease; synthesized peptides used in drug discovery of various pharmaceuticals for the treatment of various to different diseases and medical conditions; chemical preparations used in drug discovery for the treatment of various diseases and medical conditions and for pharmaceutical purposes; pharmaceutical preparations for the treatment of vario...
